Circ Biosciences
2 known investors
Circ Biosciences develops a cellular reprogramming platform to generate replacement cells that restore function in degenerative diseases where traditional therapeutics lack viable targets. The platform targets conditions caused by cell damage or loss.
BiotechDeep TechMedical Devices